Risks

Low liquidity ratios versus larger healthcare distributors increase refinancing and working-capital sensitivity, while peers with stronger balance sheets can absorb reimbursement or volume shocks more easily.

Negative interest coverage versus peers signals earnings pressure on fixed charges, limiting OMI’s flexibility if hospital demand softens or supplier terms tighten across the sector.

A long cash-conversion cycle driven by elevated receivables versus faster-turning peers raises funding needs, making growth less self-financing in a higher-rate environment.

Thin current and quick ratios versus direct distributors leave less buffer for supply disruptions or customer payment delays, increasing execution risk relative to better-capitalized peers.

Opportunities

Net debt remains modest versus EBITDA, giving OMI more room than highly levered peers to support inventory, absorb reimbursement timing, and pursue selective growth.

Inventory turns are relatively efficient versus broader distributors, which can support service levels and margin stability if demand normalizes faster than peers expect.

Lower leverage versus many healthcare supply peers improves resilience if hospital purchasing remains uneven, allowing OMI to compete on availability without stretching the balance sheet.

Working-capital discipline in inventory management can partially offset receivables drag versus peers, preserving operating flexibility as payer and customer cycles remain extended.

Overall Score

OMI’s modest leverage and efficient inventory management support positioning versus peers, but weak liquidity and coverage metrics keep working-capital and financing risks material.